CellaVision AB
STO:CEVI
CellaVision AB
STO:CEVI
Price:
227.5 SEK
0.89%
Market Closed
Updated:
May 3, 2024
CellaVision AB
Net Income (Common)
|
CellaVision AB
Net Income (Common) Peer Comparison
Comparables:
EKTA B
GETI B
ARJO B
ELOS B
SEDANA
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
CellaVision AB
STO:CEVI
|
Net Income (Common)
kr130.3m
|
CAGR 3-Years
13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
21%
|
|
|
Elekta AB (publ)
STO:EKTA B
|
Net Income (Common)
kr943m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
N/A
|
|
|
Getinge AB
STO:GETI B
|
Net Income (Common)
kr2.4B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Arjo AB (publ)
STO:ARJO B
|
Net Income (Common)
kr480m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
|
Elos Medtech AB
STO:ELOS B
|
Net Income (Common)
kr75.1m
|
CAGR 3-Years
25%
|
CAGR 5-Years
27%
|
CAGR 10-Years
N/A
|
|
|
Sedana Medical AB (publ)
STO:SEDANA
|
Net Income (Common)
-kr59.6m
|
CAGR 3-Years
-30%
|
CAGR 5-Years
-54%
|
CAGR 10-Years
N/A
|
See Also
What is CellaVision AB's Net Income (Common)?
Net Income (Common)
130.3m
SEK
130.3m
SEK
Based on the financial report for Dec 31, 2023, CellaVision AB's Net Income (Common) amounts to 130.3m SEK.
What is CellaVision AB's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
21%
21%
Over the last year, the Net Income (Common) growth was 10%. The average annual Net Income (Common) growth rates for CellaVision AB have been 13% over the past three years , 8% over the past five years , and 21% over the past ten years .
You don't have any saved screeners yet
